Volume 38; Issue supp-S11

Seminars in Hematology

Volume 38; Issue supp-S11
1

The rationale for pathogen inactivation treatment of platelet components—Introduction

Year:
2001
Language:
english
File:
PDF, 317 KB
english, 2001
3

Preclinical safety of a nucleic acid-targeted helinx TM compound: A clinical perspective

Year:
2001
Language:
english
File:
PDF, 1.16 MB
english, 2001
5

Inactivation of cytomegalovirus in platelet concentrates using helinx™ technology

Year:
2001
Language:
english
File:
PDF, 818 KB
english, 2001